Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Event Details

Filter
UKConference

Asthma And COPD

SMi is pleased to present the return of the 14th annual Asthma And COPD Conference taking place on 11th - 12th April 2018, London, UK.

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Open to all

Details

Recent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars, the need for guideline updates from regulators has increased and continues to be modified.

With asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide, opportunities in drug development are vast and reducing serious attacks by improving adherence could save $19 billion a year in U.S. healthcare costs.

Join us as we discuss current clinical trials and the innovative digital technology being used to improve clinical adherence. Leading industry experts will be looking at the use of 'real world data' human factors in the design of medical devices and triple combination treatments on the market. We will also be looking at asthma and COPD Phenotyping and biomarker application and differences between in the EU and US for the approval of biologics. We will be exploring the complexities of dry powder formulation and helping you determine clinical efficacy and endpoints.

Topics of Discussion for 2018
- Early detection and prevention of COPD and Asthma
- The use of triple combination therapies
- Health economics and market access for innovative treatments
- Regulatory updates in bioequivalence and drug-device combinations
- Enhancing dry powder formulation
- Asthma and COPD Phenotyping and biomarker application for personalised medicines

Featured Speakers:

- Wisia Wedzicha, Professor of Respiratory Medicine and Head of Respiratory Clinical Science, Imperial College London
- Quan Yang, Senior Pharmaceutical Assessor, MHRA
- Maria Gerhardsson de Verdier, Director of Epidemiology, AstraZeneca
- Rene van der Merwe, Senior Director Respiratory And Inflammation, MedImmune
- Alison Moore, Clinical Development Director, GSK 
- Peter Barnes, Head of Respiratory Medicine, Imperial College London

Prices

Book by 15th December and save £400: GBP 1099, Book by 31st January and save £200: GBP 1299, Book by 28th February and save £100: GBP 1399, Standard: GBP 1499

Contact

Kyra Williams
kwilliams@smi-online.co.uk

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.